Practical cancer cachexia management in palliative care - a review of current evidence.

Curr Opin Support Palliat Care

The Cancer Cachexia Society.

Published: September 2023

Purpose Of Review: To explore the current evidence relating to the practical management of cancer cachexia in palliative care.

Recent Findings: The authors found a growing evidence base including the publication of several expert guidelines since 2020. Guidelines identified the need for individualised nutritional and physical exercise support as the mainstay of cachexia management. Dietician and allied health professional referrals are recommended for the best patient outcomes. Limitations of nutritional support and exercise are acknowledged. Patient outcomes from multimodal anti-cachexia therapy are awaited at this time. Communication about the mechanisms of cachexia and nutritional counselling are identified as ways to reduce distress. Evidence supporting the use of pharmacological agents remains insufficient to make recommendations. Corticosteroids and progestins may be offered for symptom relief in refractory cachexia, taking into consideration well-documented side effects. Emphasis is placed on adequately managing nutritional impact symptoms. A specific role for palliative care clinicians and the use of existing palliative care guidelines in managing cancer cachexia were not identified.

Summary: Current evidence recognises the inherently palliative nature of cancer cachexia management, and practical guidance correlates with the tenets of palliative care. Individualised approaches to support nutritional intake, physical exercise and alleviate symptoms that accelerate cachexia processes are currently recommended.

Download full-text PDF

Source
http://dx.doi.org/10.1097/SPC.0000000000000655DOI Listing

Publication Analysis

Top Keywords

cancer cachexia
16
palliative care
16
cachexia management
12
current evidence
12
cachexia
8
physical exercise
8
patient outcomes
8
palliative
6
evidence
5
nutritional
5

Similar Publications

Peripheral, central, and chemotherapy-induced neuropathic changes in pancreatic cancer.

Trends Neurosci

December 2024

State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200240, PR China. Electronic address:

In pancreatic cancer, significant alterations occur in the local nervous system, including axonogenesis, neural remodeling, perineural invasion, and perineural neuritis. Pancreatic cancer can impact the central nervous system (CNS) through cancer cell-intrinsic factors or systemic factors, particularly in the context of cancer cachexia. These peripheral and central neuropathic changes exert substantial influence on cancer initiation and progression.

View Article and Find Full Text PDF

Disrupted methionine cycle triggers muscle atrophy in cancer cachexia through epigenetic regulation of REDD1.

Cell Metab

December 2024

State Key Laboratory of Analytical Chemistry for Life Science, Medical School, Nanjing University, Nanjing 210093, China; Center for Translational Medicine and Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing 210093, China. Electronic address:

The essential amino acid methionine plays a pivotal role in one-carbon metabolism, facilitating the production of S-adenosylmethionine (SAM), a critical supplier for DNA methylation and thereby a modulator of gene expression. Here, we report that the methionine cycle is disrupted in skeletal muscle during cancer cachexia, leading to endoplasmic reticulum stress and DNA hypomethylation-induced expression of the DNA damage inducible transcript 4 (Ddit4) gene, encoding the regulated in development and DNA damage response 1 (REDD1) protein. Targeting DNA methylation by depletion or pharmacological inhibition of DNA methyltransferase 3A (DNMT3A) exacerbates cachexia, while restoring DNMT3A expression or REDD1 knockout alleviates cancer cachexia-induced skeletal muscle atrophy in mice.

View Article and Find Full Text PDF

Cancer cachexia is a debilitating syndrome characterized by progressive weight loss, muscle wasting, and systemic inflammation. Despite the prevalence and severe consequences of cancer cachexia, effective treatments for this syndrome remain elusive. Therefore, there is a greater need for well-characterized animal models to identify novel therapeutic targets.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates the effectiveness of single-slice versus multi-slice computed tomography (CT) methods in analyzing body composition in patients with oesophagogastric cancer, focusing on their correlation and impact on survival rates.
  • Researchers examined CT scans of 504 patients, comparing measurements of skeletal muscle, subcutaneous, visceral, and intermuscular adipose tissue, finding high correlation and narrow limits of agreement between the two methods.
  • Results indicate that both measurement techniques offer similar insights into body composition, suggesting that the clinical use of multi-slice analyses may be beneficial but requires further exploration for optimal application.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!